Toll-like receptor agonist formulations and their use

Details Toll-like receptor agonist formulations and their use Toll-like receptor agonist formulations and their use

A - Human Necessities

61

K

A61K 31/55 (2006.01) A61P 17/00 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2732437

The present invention is directed generally to stable formulations of a TLR agonist preferably a TLR7 or a TLR8 agonist, for use in the treatment of cancer, preferably solid tumors and lymphomas. Specifically, the present invention is directed to stable formulations of up to 50 mg/ml of a TLR agonist which comprise a cyclodextrin.

La présente invention porte d'une manière générale sur des formulations stables d'un agoniste de TLR, de préférence, un agoniste de TLR7 ou de TLR8, pour une utilisation dans le traitement du cancer, de préférence, de tumeurs solides et de lymphômes. La présente invention porte spécifiquement sur des formulations stables allant jusqu'à 50 mg/ml d'un agoniste de TLR qui comprend une cyclodextrine.

Affiliated with

Also associated with

Rating

Toll-like receptor agonist formulations and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Toll-like receptor agonist formulations and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toll-like receptor agonist formulations and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1341809